Description
Your doctor may prescribe Zyclara if you have specific skin conditions such as actinic keratosis (AK) on the face or scalp. AK manifests as rough, scaly patches resulting from prolonged sun exposure and poses a risk of progressing to skin cancer.
Imiquimod modifies the immune response. It stimulates both the innate and adaptive immune systems and induces the release of cytokines like interferon-alpha. These mediators bolster the immune response, aiding in the identification and elimination of abnormal cells, including those characteristic of actinic keratosis.
Fact Table
|
Formula
|
C14H16N4
|
License
|
US FDA
|
Bioavailability
|
~0.9% (topical)
|
Legal status
|
Prescription only (?)
|
Chemical Name
|
1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine
|
Elimination half-life
|
~30 hours
|
Dosage (Strength)
|
2.5%, 3.75%, 5% cream
|
Pregnancy
|
Use with caution
|
Brands
|
Zyclara, Aldara
|
Protein binding
|
~93%
|
PubChem CID
|
57469
|
MedlinePlus
|
a698010
|
ChEBI
|
CHEBI:37980
|
ATC code
|
D06BB10
|
DrugBank
|
DB00724
|
KEGG
|
D08067
|
Routes of administration
|
Topical
|
Directions
Zyclara is applied topically once daily to the affected area.
To treat actinic keratosis, Zyclara is typically applied for two weeks, followed by a two-week break, and then another two-week treatment cycle if necessary.
Wash and dry the area gently and thoroughly before applying Zyclara.
Ingredients
The active ingredient in Zyclara is imiquimod.
Interactions
There are no significant drug-drug interactions between Zyclara and other medications
Cautions
Discontinue Zyclara and consult a healthcare provider if severe systemic reactions like allergic hypersensitivity occur. Symptoms include trouble breathing, hives, and swelling of the airway.
You and your doctor should monitor for local skin reactions such as redness, swelling, and erosion, which may necessitate treatment interruption.
Tell your doctor if you have a history of problems with your immune system because Zyclara can worsen these conditions.
Avoid sun exposure and tanning beds during Zyclara use to reduce the risk of increased sunburn susceptibility. Wear protective clothing and apply sunscreen when outdoors.
Side Effects
Adverse reactions to Zyclara include:
- Application site reaction
- Burning sensation
- Cardiac dysrhythmia
- Cerebrovascular accident
- Edematous skin
- Erythema
- Erythema multiforme
- Erythroderma
- Female genital edema
- Headache
- Heart failure
- Immune thrombocytopenia
- Influenza-like illness
- Myocardial infarction
- Peeling of skin
- Pruritus
- Scab of skin
- Skin discharge
- Skin ulcer
- Syncope
- Upper respiratory infection
References
Zyclara [package insert]. Bristol, TN: Graceway; March 2010.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 11615